Correction: Variations in Predictive Value of Serum Uric Acid for Major Adverse Cardiovascular Events by Gender in Acute Coronary Syndrome Patients: A Retrospective Cohort Analysis - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Correction: Variations in Predictive Value of Serum Uric Acid for Major Adverse Cardiovascular Events by Gender in Acute Coronary Syndrome Patients: A Retrospective Cohort Analysis
Clinical Scorecard: Correction: Variations in Predictive Value of Serum Uric Acid for Major Adverse Cardiovascular Events by Gender in Acute Coronary Syndrome Patients: A Retrospective Cohort Analysis
At a Glance
Category
Detail
Condition
Acute Coronary Syndrome
Key Mechanisms
Serum Uric Acid levels as a predictive biomarker
Target Population
Patients with Acute Coronary Syndrome
Care Setting
Cardiovascular care
Key Highlights
Study focuses on gender differences in predictive value of serum uric acid
Major adverse cardiovascular events analyzed
Retrospective cohort study design
Correction of previously published figures
Implications for risk stratification in ACS patients
Guideline-Based Recommendations
Diagnosis
Assess serum uric acid levels in patients with ACS
Management
Consider gender-specific approaches in managing ACS
Monitoring & Follow-up
Regular monitoring of serum uric acid in ACS patients
Risks
Evaluate risks associated with elevated serum uric acid levels
Patient & Prescribing Data
Patients diagnosed with Acute Coronary Syndrome
Potential role of uric acid in cardiovascular risk assessment
Clinical Best Practices
Incorporate serum uric acid measurement in routine ACS evaluation
Utilize gender-specific data for risk assessment
Ensure accurate representation of data in clinical publications
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
